Supports Healthy Metabolic Function*
Similarly, analyses of GLP-1RA cardiovascular outcomes trials demonstrate preserved reductions in MACE and kidney outcomes irrespective of concomitant SGLT2i therapy [15, 16]
Each IV or injectable treatment at Regenesis begins with a medical intake
Stability Information Freeze for storageRefrigerate after reconstitutionProtect from light Lyophilized (powder) -20C 24+ months Reconstituted 2-8C ~30 days Sources & References Peer-reviewed research NEW ENGLAND JOURNAL OF MEDICINE TripleHormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial 2023DOI: 10.1056/NEJMoa2301972 Jastrehoff AM, et al
I continue to come to Steve because I keep seeing benefits, from heart health to overall wellness. Contact Us Today
We produce this molecule endogenously, primarily in the liver, using the precursor amino acids cysteine, glutamine and glycine, which come from the food that we eat